Recombinant Human LAIR2/CD306 Protein
Recombinant Human LAIR2/CD306 Protein supplied by Elabscience with collaborator-provided technical specifications. Read more ›
["Measured by the ability of the immobilized protein to support the adhesion of HT-29 human colon adenocarcinoma cells. When 5 x 104 cells/well are added to recombiannt human LAIR2 coated plates (50 μg/ml with 100 μl/well), > 30% will adhere after 30 minutes at 37℃. Optimal concentration depends on cell type as well as the application or research objectives. ,22 kDa"]Product Description
LAIR2/CD306 is the stated recombinant protein target for this Elabscience product. The listing uses collaborator-supplied specifications to support research-use-only protein selection through ABMIUM.
Protein profile: reactive species/source: Human; expression system: HEK293 Cells; physical form: Lyophilized from sterile 50mM Tris, 0.7M NaCl, pH 8.0<br/>Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.<br/>Please refer to the specific buffer information in the printed manual.; tag: Human ,LAIR2/CD306 ,Recombinant Proteins; predicted molecular weight: 14.1 kDa.
Quality and formulation: purity: > 93 % as determined by reducing SDS-PAGE.; endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method..
Functional evidence: activity: Measured by the ability of the immobilized protein to support the adhesion of HT-29 human colon adenocarcinoma cells. When 5 x 10<sup>4</sup> cells/well are added to recombiannt human LAIR2 coated plates (50 μg/ml with 100 μl/well), > 30% will adhere after 30 minutes at 37℃. Optimal concentration depends on cell type as well as the application or research objectives.. In the ABMIUM matrix, collaborator-supplied functional evidence is marked C; unsupported application columns remain N.
Sequence coverage: 14.1 kDa.
Database references: UniProt: NP_002279.2 | NCBI Gene: 3904 | Gene symbol: LAIR2/CD306.
Research Use Only.
Key Facts
| Target | LAIR2/CD306 |
| Also known as | CD306, LAIR-2, LAIR2, Leukocyte-Associated Immunoglobulin-Like Receptor 2 |
| Species reactivity | Human |
| Purity | > 93 % as determined by reducing SDS-PAGE. |
| Form / buffer | Lyophilized from sterile 50mM Tris, 0.7M NaCl, pH 8.0 Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual. |
| Shelf life | 12 months |
| Research area | immunology |
| BIOACTIVITY | BINDING | CELL-BASED | IN VIVO | ELISA CAPTURE | |
|---|---|---|---|---|---|
| Human |
Specifications
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.